NuScale Power (NYSE: SMR) has filed for a follow-on equity offering of up to $750 million in Class A common stock through an at-the-market program, drawing fresh attention from investors.
The financing move arrives during a volatile stretch for the company’s shares, with the stock up 8.29% over the past month but down 42.37% year to date.
The one-year total shareholder return has declined 73.17%, though the three-year total shareholder return remains positive, presenting a mixed picture for long-term holders.
NuScale holds the only small modular reactor design currently certified by the Nuclear Regulatory Commission, a distinction that required years of work and hundreds of millions of dollars to secure.
That certification represents a meaningful competitive advantage in the emerging SMR sector, giving the company a structural edge over rivals yet to clear regulatory hurdles.
The central question for investors is whether a $750 million at-the-market program clears the way for future growth or signals that much of the upside has already been priced into the stock.
NuScale last closed at $9.40, while the most widely followed analyst narrative places fair value at $100 per share, creating a significant gap that investors must weigh against the new dilutive offering.
That bullish valuation hinges on how quickly revenue scales from its current small base, what long-run margins ultimately settle at, and how those future cash flows are discounted back to present value.
A separate discounted cash flow model estimates the company’s future cash flow value at just $2.67 per share, which would place the current $9.40 price firmly in overvalued territory.
The wide divergence between a $100 narrative fair value and a $2.67 DCF estimate reflects the fundamental uncertainty surrounding first-of-a-kind nuclear deployments at commercial scale.
Analysts and investors continue to debate how much weight a cash flow driven model should carry for a business still in its build-out phase and yet to achieve meaningful commercial revenues.
Real risks remain, including the possibility that project costs rise further or that key customers hesitate to commit capital to first-of-a-kind SMR deployments before proven operational track records exist.
The broader energy sector is undergoing rapid diversification, which many analysts view as a net positive for nuclear infrastructure companies positioned to supply reliable, low-carbon baseload power.
For investors weighing nuclear exposure within their portfolios, NuScale’s offering and the surrounding valuation debate represent a defining moment in the company’s commercial trajectory.
